Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.2.13 (
aldolase
)
3,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Reductive, nonreductive, and photolytic interactions of vanadate with fructose-1,6-bisphosphate
aldolase
were examined and used to explore the interactions of oxoanions with
aldolase
. Aldolase is known to interact strongly with oxoanions at low ionic strength and weakly at higher ionic strength. Oxoanions inhibit
aldolase
competitively with respect to fructose 1,6-bisphosphate although the location of the oxoanion binding site on
aldolase
remains elusive. In this work, the interaction of
aldolase
with a series of oxoanions was compared at ionic strength approaching physiologic levels. The size and shape of the anion were important for the effective binding to
aldolase
, and no significant increase in affinity for
aldolase
was observed by the addition of alkyl groups to the oxoanions. Vanadate competitively inhibits
aldolase
in a manner analogous to the other oxoanions. Since vanadate solutions contain a mixture of vanadate oxoanions, the nature of the inhibition was determined using a combination of enzyme kinetics and 51V NMR spectroscopy. Aldolase contains a significant number of thiol functionalities, and as expected, vanadate undergoes redox chemistry with them, generating an irreversibly inhibited
aldolase
. This oxidative chemistry was attributed to the vanadate tetramer, whereas vanadate dimer was a reversible inhibitor. Vanadate monomer does not significantly interact with
aldolase
reversibly or irreversibly. Vanadyl cation has the lowest inhibition constant under these high ionic strength conditions. Using Yonetani-Theorell analysis, it appears that phosphate, pyrophosphate, and sulfate bind to the same site on
aldolase
, whereas vanadate, arsenate, and molybdate bind to another site. UV light-induced photocleavage of
aldolase
by vanadate was examined, and the loss of
aldolase
activity was correlated with cleavage of the
aldolase
subunit. Further studies using
vanadium
as a probe should reveal details on the location of the vanadate and vanadyl cation binding sites. This study suggests several sites on
aldolase
will accommodate oxoanions, and one of these sites also accommodates vanadyl cation.
...
PMID:Interaction of rabbit muscle aldolase at high ionic strengths with vanadate and other oxoanions. 163 17
The effects of vanadate, an oxidized form of
vanadium
, on glucose metabolism of the lens in diabetic rats were studied. Five-week-old male Sprague-Dawley rats were rendered diabetic with intraperitoneal injection of streptozotocin (50 mg/kg). One week later, the diabetic rats were given 0.2 g/l NaVO3 -5g/l NaCl solution in drinking water ad libitum for 2 weeks and biochemical parameters in their lenses were determined. Blood glucose levels significantly decreased in the vanadate-administered diabetic rats (DV group), compared with the diabetic rats given no vanadate (D group). In the DV group, a significant decrease was observed in lens fructose content compared with the D group. Lens ketohexokinase activity tended to be higher and lens
aldolase
activity was significantly higher in the DV group than in the D group. These results indicate that vanadate accelerates the metabolic reaction from sorbitol pathway to glycolysis.
...
PMID:[Effects of vanadate on glucose metabolism in the lens of rats with streptozotocin-induced diabetes--ketohexokinase and aldolase activity]. 788 27